201 related articles for article (PubMed ID: 20801424)
1. Intravitreal injection of autologous plasmin enzyme for macular edema associated with branch retinal vein occlusion.
Sakuma T; Mizota A; Inoue J; Tanaka M
Am J Ophthalmol; 2010 Dec; 150(6):876-82. PubMed ID: 20801424
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal injection of autologous plasmin enzyme for macular edema associated with branch retinal vein occlusion.
Udaondo P; Garcia-Delpech S; Salom D; Garcia-Pous M; Díaz-Llopis M
Am J Ophthalmol; 2011 Aug; 152(2):326-7; author reply 327-8. PubMed ID: 21784203
[No Abstract] [Full Text] [Related]
3. Intravitreal plasmin without vitrectomy for macular edema secondary to branch retinal vein occlusion.
Udaondo P; Díaz-Llopis M; García-Delpech S; Salom D; Romero FJ
Arch Ophthalmol; 2011 Mar; 129(3):283-7. PubMed ID: 21402982
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edema: nine-month results of a prospective study.
Rouvas A; Petrou P; Ntouraki A; Douvali M; Ladas I; Vergados I
Retina; 2010 Jun; 30(6):893-902. PubMed ID: 20531142
[TBL] [Abstract][Full Text] [Related]
5. Role of posterior vitreous detachment induced by intravitreal tissue plasminogen activator in macular edema with central retinal vein occlusion.
Murakami T; Takagi H; Ohashi H; Kita M; Nishiwaki H; Miyamoto K; Watanabe D; Sakamoto A; Yamaike N; Yoshimura N
Retina; 2007 Oct; 27(8):1031-7. PubMed ID: 18040240
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion.
Patel PJ; Zaheer I; Karia N
Eye (Lond); 2008 Jan; 22(1):60-4. PubMed ID: 16902493
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal triamcinolone acetonide in patients with macular oedema due to branch retinal vein occlusion: a pilot study.
Krepler K; Ergun E; Sacu S; Richter-Müksch S; Wagner J; Stur M; Wedrich A
Acta Ophthalmol Scand; 2005 Oct; 83(5):600-4. PubMed ID: 16188000
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal tissue plasminogen activator to treat macular edema associated with branch retinal vein occlusion.
Murakami T; Takagi H; Kita M; Nishiwaki H; Miyamoto K; Ohashi H; Watanabe D; Yoshimura N
Am J Ophthalmol; 2006 Aug; 142(2):318-20. PubMed ID: 16876516
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion.
Hayashi K; Hayashi H
Am J Ophthalmol; 2005 Jun; 139(6):972-82. PubMed ID: 15953425
[TBL] [Abstract][Full Text] [Related]
10. Early treatment of cystoid macular edema secondary to branch retinal vein occlusion with intravitreal triamcinolone acetonide.
Yepremyan M; Wertz FD; Tivnan T; Eversman L; Marx JL
Ophthalmic Surg Lasers Imaging; 2005; 36(1):30-6. PubMed ID: 15688969
[TBL] [Abstract][Full Text] [Related]
11. Microperimetric changes after intravitreal triamcinolone acetonide injection for macular edema due to central retinal vein occlusion.
Senturk F; Ozdemir H; Karacorlu M; Karacorlu SA; Uysal O
Retina; 2010 Sep; 30(8):1254-61. PubMed ID: 20827142
[TBL] [Abstract][Full Text] [Related]
12. Impact of intravitreal injection of tissue plasminogen activator on full-field electroretinogram in patients with macular oedema secondary to retinal vein occlusion.
Tagami M; Kusuhara S; Imai H; Honda S; Tsukahara Y; Negi A
Ophthalmologica; 2011; 226(2):81-6. PubMed ID: 21625191
[TBL] [Abstract][Full Text] [Related]
13. Predictability of vitreous detachment following intravitreal plasmin injection in diabetic macular edema associated with vitreomacular traction.
Elbendary AM; Elwan MM; Azzam HA; Eldeeb DR
Curr Eye Res; 2011 Jun; 36(6):534-9. PubMed ID: 21591862
[TBL] [Abstract][Full Text] [Related]
14. Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study.
Brown DM; Campochiaro PA; Bhisitkul RB; Ho AC; Gray S; Saroj N; Adamis AP; Rubio RG; Murahashi WY
Ophthalmology; 2011 Aug; 118(8):1594-602. PubMed ID: 21684606
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal triamcinolone acetonide in patients with macular oedema due to central retinal vein occlusion.
Krepler K; Ergun E; Sacu S; Richter-Müksch S; Wagner J; Stur M; Wedrich A
Acta Ophthalmol Scand; 2005 Feb; 83(1):71-5. PubMed ID: 15715561
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation.
Cakir M; Dogan M; Bayraktar Z; Bayraktar S; Acar N; Altan T; Kapran Z; Yilmaz OF
Retina; 2008 Mar; 28(3):465-72. PubMed ID: 18327140
[TBL] [Abstract][Full Text] [Related]
17. Antagonism of vascular endothelial growth factor for macular edema caused by retinal vein occlusions: two-year outcomes.
Campochiaro PA; Hafiz G; Channa R; Shah SM; Nguyen QD; Ying H; Do DV; Zimmer-Galler I; Solomon SD; Sung JU; Syed B
Ophthalmology; 2010 Dec; 117(12):2387-2394.e1-5. PubMed ID: 20630595
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal triamcinolone acetonide for cystoid macular edema in nonischemic central retinal vein occlusion.
Williamson TH; O'Donnell A
Am J Ophthalmol; 2005 May; 139(5):860-6. PubMed ID: 15860292
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal triamcinolone for the treatment of ischemic macular edema associated with branch retinal vein occlusion.
Chen SD; Sundaram V; Lochhead J; Patel CK
Am J Ophthalmol; 2006 May; 141(5):876-883. PubMed ID: 16527226
[TBL] [Abstract][Full Text] [Related]
20. Macular hole after injection of dexamethasone intravitreal implant for macular oedema due to central retinal vein occlusion.
De Benedetto U; Battaglia Parodi M; Knutsson KA; Lattanzio R; Bandello F; Iacono P
Acta Ophthalmol; 2013 Feb; 91(1):e75-7. PubMed ID: 22863290
[No Abstract] [Full Text] [Related]
[Next] [New Search]
